IL37 and hepatocellular carcinoma: In conclusion, these findings suggest that IL-37 polymorphisms may not only be implicated in the development of HCC but may also be involved in HBV infection and in determining different clinical outcomes of HBV infection, including active chronic HBV infection and low viremic “inactive” HBsAg carrier status.